Minnesota · 86828

Assessment Of Antibodies To Class I And Class Ii Human Leukocyte Antigens (hla) Antigens in Minnesota

Minnesota Medicare Avg
$61.23
2% below national avg
National Medicare Avg
$62.41
All states combined
Billed Charge (MN)
$179.67
What providers submit
Est. Commercial (MN)
$133.47
National avg: $139.79
Est. Cash / Self-Pay (MN)
$95.33
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

30
Services in MN
15
Providers
N/A
Min Payment
N/A
Max Payment

Minnesota Pricing in Context

In Minnesota, CPT code 86828 (Assessment Of Antibodies To Class I And Class Ii Human Leukocyte Antigens (hla) Antigens) carries an average Medicare payment of $61.23 — 2% below the national benchmark of $62.41. 15 providers across the state submitted claims for this procedure in 2023, performing 30 total services. Individual payments in MN ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Minnesota is $179.67, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Minnesota sits below the national Medicare average, commercial rates in the state may also run lower than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Immunology procedures, the estimated commercial insurance price in Minnesota lands near $133.47, with self-pay cash prices typically around $95.33. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Assessment Of Antibodies To Class I And Class Ii Human Leukocyte Antigens (hla) Antigens cost in Minnesota?

The average Medicare payment for Assessment Of Antibodies To Class I And Class Ii Human Leukocyte Antigens (hla) Antigens in Minnesota is $61.23, which is 2% below the national average of $62.41. Providers in MN typically bill $179.67 for this procedure.

What does Assessment Of Antibodies To Class I And Class Ii Human Leukocyte Antigens (hla) Antigens cost with insurance in Minnesota?

With commercial insurance in Minnesota, Assessment Of Antibodies To Class I And Class Ii Human Leukocyte Antigens (hla) Antigens costs an estimated $133.47. Without insurance, the estimated cash price is $95.33. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Assessment Of Antibodies To Class I And Class Ii Human Leukocyte Antigens (hla) Antigens in Minnesota?

15 providers in Minnesota billed Medicare for Assessment Of Antibodies To Class I And Class Ii Human Leukocyte Antigens (hla) Antigens in 2023, performing 30 total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Assessment Of Antibodies To Class I And Class Ii Human Leukocyte Antigens (hla) Antigens cheaper in Minnesota than the national average?

Yes — Assessment Of Antibodies To Class I And Class Ii Human Leukocyte Antigens (hla) Antigens costs 2% below the national average in Minnesota. The state average Medicare payment is $61.23 compared to $62.41 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial